Alcoa Schedules Second Quarter 2023 Earnings Release and Conference Call

Alcoa Schedules Second Quarter 2023 Earnings Release and Conference Call

PITTSBURGH–(BUSINESS WIRE)–
Alcoa Corporation plans to announce its second quarter 2023 financial results on Wednesday, July 19, after the close of trading on the New York Stock Exchange.

The press release with financial results, and a related presentation, will be available on the “Investors” section of Alcoa’s website, www.alcoa.com. A link to the press release will also be on Alcoa’s Twitter handle @Alcoa at www.twitter.com/Alcoa.

A conference call to discuss the financial results will begin at 5:00 p.m. EDT, and will be webcast live via Alcoa’s website, www.alcoa.com.

Conference Call Information

Time

Wednesday, July 19, 2023: 5:00 p.m.– 6:00 p.m. EDT

 

 

Hosts:

Roy Harvey, President and Chief Executive Officer

 

Molly Beerman, Executive Vice President and Chief Financial Officer

Webcast:

Go to the “Investors” section of the Alcoa website to listen only and view presentation slides.

 

Call:

+1 (877) 883-0383 (Domestic)

 

+1 (412) 902-6506 (International)

 

Conference ID: 5022765

 

To avoid a delay in start time, please dial in beginning at 4:45 p.m.

 

 

Replay Information:

 

A telephone replay will be available at approximately 8:00 p.m. EDT on July 19 until July 26, 2023.

+1 (877) 344-7529 (Domestic)

 

+1 (412) 317-0088 (International)

 

Replay Access Code: 6008876

 

To access the replay using an international dial-in number, please select this link: https://services.choruscall.com/ccforms/replay.html

 
The webcast will also be archived on the “Events & Presentations” portion of the “Investors” section of www.alcoa.com at this link: https:/investors.alcoa.com/events-and-presentations/

About Alcoa Corporation

Alcoa (NYSE: AA) is a global industry leader in bauxite, alumina and aluminum products with a vision to reinvent the aluminum industry for a sustainable future. With a values-based approach that encompasses integrity, operating excellence, care for people and courageous leadership, our purpose is to Turn Raw Potential into Real Progress. Since developing the process that made aluminum an affordable and vital part of modern life, our talented Alcoans have developed breakthrough innovations and best practices that have led to greater efficiency, safety, sustainability and stronger communities wherever we operate.

Dissemination of Company Information

Alcoa intends to make future announcements regarding company developments and financial performance through its website, www.alcoa.com, as well as through press releases, filings with the Securities and Exchange Commission, conference calls, and webcasts.

Investor Contact:

James Dwyer

412-992-5450

[email protected]

Media Contact:

Jim Beck

412-315-2909

[email protected]

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Machine Tools, Metalworking & Metallurgy Manufacturing

MEDIA:

Logo
Logo

CoolCo Announces Exercise of Purchase Option for two 2-stroke LNG Carrier Newbuilds

Vessels are amongst the few scheduled to deliver in 2024 still available for time charter employment

Acquisition price approximately 10% below current yard pricing, with 3-year earlier delivery

Cool Company Limited (NYSE: CLCO / CLCO.OL “CoolCo” or the “Company”) announces today that it has exercised its option to acquire two newbuild 2-stroke LNG carriers from affiliates of EPS Ventures Ltd (“EPS”). The state-of-the-art MEGA LNG carriers (the “Newbuilds”) are scheduled to deliver from Hyundai Samho Heavy Industries (“HHI”) in Korea in September and December of 2024. The Newbuilds have a cargo capacity of 174,000 cbm, a GTT Mark III Flex Membrane cargo tank system, reliquification, air-lubrication and shaft generators. Each of the two Newbuilds is being acquired under the pre-existing purchase option price of approximately $234 million, a discount of approximately 10% to current quoted market value for comparable newbuild vessels. The initial exercise price is approximately $57 million per vessel, while approximately $134 million of the remaining $177m is due upon delivery of each of the vessels. The expected closing date and payment of the option exercise is Monday July 3, 2023.

The Newbuilds, to be named Kool Tiger and Kool Panther, are expected to be funded with a combination of cash on hand, including cash that was recently released from the sale of the Golar Seal, and debt financing for which CoolCo has received a commitment letter from a financing institution. This debt financing, which is subject to customary approvals, is on a fixed rate per day basis for 10 years with a minimum loan-to-value of 80% and an implied interest rate of around 6%. We do not anticipate needing to raise additional equity to finance the two Newbuilds.

Richard Tyrrell, CEO, commented:

We look forward to welcoming these state-of-the-art vessels into the CoolCo fleet at a material discount to their current market value. Their 2024 delivery date makes the vessels especially attractive, with comparable vessels ordered today only being delivered in the 2027/28 timeframe. The vessels’ best-in-class design and boil-off rate make them highly attractive to charterers who benefit from the ability to operate efficiently at a range of speeds with reduced emissions.

With the vast majority of the global LNG carrier orderbook already committed to liquefaction projects coming online in the years ahead, few, if any, modern LNG carriers are expected to be available for time charter employment during the late 2024 window when the vessels deliver. We are currently in discussions to forward fix the vessels on long-term time charters and expect to do so well in advance of delivery at levels that reflect current market strength.

About CoolCo

CoolCo is a growth-oriented owner, operator and manager of fuel-efficient liquefied natural gas (“LNG”) carriers. Using its integrated, in-house vessel management platform, CoolCo provides charterers and third-party LNG vessel owners with modern and flexible management and transportation solutions, delivering a lesser-emitting form of energy that supports decarbonization efforts, economic growth, energy security, and improvements in quality of life. CoolCo intends to leverage its industry relationships to make further accretive acquisitions of in-service LNGCs, and to selectively pursue newbuild opportunities.

For further information, please contact:

[email protected]

Forward-looking Statements

This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995, including statements with respect to the delivery dates for the Newbuilds and their performance capacities, the market for newbuild LNG carriers, our ability to conclude any debt financing and the specific terms, the LNG carrier orderbook and market, the conclusion and terms of any charters for the Newbuilds, and other non-historical statements.  Forward-looking statements are typically identified by words or phrases, such as “about”, “believe,” “expect,” “plan,” “goal,” “target,” “strategy,” and similar expressions or future or conditional verbs such as “may,” “will,” “should,” “would,” and “could.” These statements are based on current expectations, estimates, assumptions and projections and you should not place undue reliance on them. Forward-looking statements do not guarantee future performance and involve risks and uncertainties. These risks and uncertainties include risks relating to this contract, future industry conditions and other risks indicated in the risk factors included in CoolCo’s Annual Report on Form 20-F for the year ended December 31, 2022 and other filings with the U.S. Securities and Exchange Commission. These forward-looking statements are made only as of the date of this document. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

This information is subject to the disclosure requirements in Regulation EU 596/2014 (MAR) article 19 number 3 and section 5-12 of the Norwegian Securities Trading Act.

Cool Company Ltd.

Hamilton, Bermuda

Questions should be directed to:

c/o Cool Company Management Ltd – +44 207 659 1111 / [email protected]

Richard Tyrrell – Chief Executive Officer

John Boots – Chief Financial Officer

 



CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

BERKELEY HEIGHTS, N.J., June 28, 2023 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced that it intends to offer and sell shares of its common stock, and in lieu of common stock to certain investors that so chose, pre-funded warrants to purchase shares of its common stock, in an underwritten public offering. All of the shares and pre-funded warrants to be sold in the offering will be offered by CorMedix. In addition, CorMedix intends to grant the underwriters a 30-day option to purchase up to an additional 15% of shares of its common stock offered in the public offering (including shares underlying the pre-funded warrants), at the public offering price, less underwriting discounts and commissions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

RBC Capital Markets, Truist Securities and JMP Securities, a Citizens Company, are acting as book-running managers for the offering.

CorMedix intends to use the net proceeds from the proposed public offering for general corporate purposes, commercialization efforts, research and development, and working capital and general expenditures.

The securities described above are being offered by CorMedix pursuant to a shelf registration statement on Form S-3 (File No. 333-258756) which was initially filed by CorMedix with the Securities and Exchange Commission (the “SEC”) on August 12, 2021, and was declared effective by the SEC on August 20, 2021.

The securities will be offered only by means of a prospectus supplement and accompanying prospectus relating to the offering that form a part of the registration statement. A preliminary prospectus supplement and the accompanying prospectus relating to and describing the terms of the offering will be filed with the SEC and will be available on the SEC’s website at http://www.sec.gov. Copies of the preliminary prospectus supplement and accompanying base prospectus relating to the offering, as well as copies of the final prospectus supplement, when available, may be obtained from RBC Capital Markets, LLC, Attention: Equity Capital Markets, 200 Vesey Street, 8th Floor, New York, NY 10281, by telephone at (877) 822-4089, or by email at [email protected]; Truist Securities, Inc., Attention: Prospectus Department, 3333 Peachtree Road NE, 9th floor, Atlanta, Georgia 30326, by telephone at (800) 685-4786, or by email at [email protected]; or JMP Securities LLC, Attention: Prospectus Department, 600 Montgomery Street, Suite 1100, San Francisco, California 94111, by telephone at (415) 835-8985, or by e-mail at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About CorMedix Inc.

CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on developing its lead product DefenCath, a novel, non-antibiotic antimicrobial and antifungal solution designed to prevent costly and life-threatening bloodstream infections associated with the use of central venous catheters in patients undergoing chronic hemodialysis. DefenCath has been designated by FDA as Fast Track and as a Qualified Infectious Disease Product (QIDP), and the original New Drug Application (NDA) received priority review in recognition of its potential to address an unmet medical need. QIDP provides for an additional five years of marketing exclusivity, which will be added to the five years granted to a New Chemical Entity upon approval of the NDA. CorMedix also committed to conducting a clinical study in pediatric patients using a central venous catheter for hemodialysis when the NDA is approved, which will add an additional six months of marketing exclusivity when the study is completed. CorMedix received a second Complete Response Letter from the FDA last August related to deficiencies at both its primary contract manufacturer and its supplier of heparin API. After receiving guidance from FDA at a Type A meeting in April of 2023, the NDA for DefenCath was resubmitted. In June of 2023, the NDA was accepted for filing by the FDA. CorMedix also intends to develop DefenCath as a catheter lock solution for use in other patient populations, and the company is working with top-tier researchers to develop taurolidine-based therapies for rare pediatric cancers. For more information visit: www.cormedix.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are subject to risks and uncertainties. All statements, other than statements of historical facts, regarding management’s expectations, beliefs, goals, plans or CorMedix’s prospects, including, but not limited to, statements regarding the offer and sale of common stock, the terms of the offering, the expected use of proceeds, CorMedix’s future financial position, financing plans, future revenues, projected costs and the sufficiency of our cash and short-term investment to fund our operations are forward-looking statements reflecting the current beliefs and expectations of management should be considered forward-looking. Readers are cautioned that actual results may differ materially from projections or estimates due to a variety of important factors, including: the risks and uncertainties related to market conditions; satisfaction of customary closing conditions related to the offering; and as risks and uncertainties set forth in CorMedix’s Annual Report on Form 10-K for the year ended December 31, 2022, and the preliminary prospectus supplement related to the proposed public offering and subsequent filings with the SEC. These and other risks are described in greater detail in CorMedix’s filings with the SEC, copies of which are available free of charge at the SEC’s website at www.sec.gov or upon request from CorMedix. CorMedix may not actually achieve the goals or plans described in its forward-looking statements, and investors should not place undue reliance on these statements. CorMedix assumes no obligation and does not intend to update these forward-looking statements, except as required by law.

Investor Contact:

Dan Ferry
Managing Director
LifeSci Advisors
(617) 430-7576



TechTarget to Announce 2023 Second Quarter Financial Results on August 8, 2023

TechTarget to Announce 2023 Second Quarter Financial Results on August 8, 2023

Live Conference Call and Webcast Scheduled to Begin at 5:00 p.m. ET

NEWTON, Mass.–(BUSINESS WIRE)–
TechTarget, Inc. (Nasdaq: TTGT), the global leader in B2B technology purchase intent data and services today announced that it plans to release its 2023 second quarter financial results after the market closes on Tuesday, August 8, 2023. The Company’s management team will host a live conference call and webcast at 5:00 p.m. Eastern Daylight Time on that day to discuss the Company’s financial results. In conjunction with the announcement and the call, the Company will distribute an update on the business, current market conditions, operational, and financial results for the applicable period, and other matters, with the call being reserved for a summary of financial highlights by management and Q&A. The financial results and a letter to shareholders will be accessible prior to the conference call and webcast on the investor information section of the Company’s website at https://investor.techtarget.com.

Conference Call Dial-In Information:

  • United States (Toll Free): +1 833 470 1428

  • United States: +1 404 975 4839

  • Canada (Toll Free): 1 833 950 0062

  • Canada: 1 226 828 7575

  • United Kingdom (Toll Free): +44 808 189 6484

  • United Kingdom: +44 20 8068 2558

  • Access code: 032486

  • Please access the call at least 10 minutes prior to the time the conference is set to begin.

  • Please ask to be joined into the TechTarget call.

Conference Call Webcast Information:

This webcast can be accessed via TechTarget’s website at https://investor.techtarget.com.

Conference Call Replay Information:

A replay of the conference call will be available via telephone after the conference call through August 31, 2023. To hear the replay:

  • United States (Toll Free): 1 866 813 9403

  • United States: 1 929 458 6194

  • Canada: 1 226 828 7578

  • United Kingdom: 0204 525 0658

  • Access Code: 825049

A web version will also be available for replay on https://investor.techtarget.com during the same period.

About TechTarget

TechTarget (Nasdaq: TTGT) is the global leader in purchase intent-driven marketing and sales services that deliver business impact for enterprise technology companies. By creating abundant, high-quality editorial content across approximately 150 websites and 1,000 webinars and virtual event channels, TechTarget attracts and nurtures communities of technology buyers researching their companies’ information technology needs. By understanding these buyers’ content consumption behaviors, TechTarget creates the purchase intent insights that fuel efficient and effective marketing and sales activities for clients around the world.

TechTarget has offices in Boston, London, Munich, New York, Paris, Singapore and Sydney. For more information, visit techtarget.com and follow us on Twitter @TechTarget.

©2023 TechTarget, Inc. All rights reserved. TechTarget and the TechTarget logo are registered trademarks of TechTarget. All other trademarks are the property of their respective owners.

Investor Inquiries

Daniel Noreck

Chief Financial Officer

TechTarget, Inc.

617-431-9449

[email protected]

Media Inquiries

Garrett Mann

Director of Marketing

TechTarget, Inc.

617-431-9371

[email protected]

KEYWORDS: Massachusetts United States North America

INDUSTRY KEYWORDS: Technology Publishing Advertising Communications Professional Services Software Internet Digital Marketing Data Analytics

MEDIA:

Logo
Logo

Intuit Names Mark Notarainni General Manager of Consumer Group

Intuit Names Mark Notarainni General Manager of Consumer Group

Creator of Company’s Assisted Tax Strategy and Leader of Intuit Virtual Expert Platform to Helm TurboTax

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Intuit Inc. (Nasdaq: INTU), the global financial technology platform that makes Intuit TurboTax, Credit Karma, QuickBooks, and Mailchimp, named Mark Notarainni General Manager of its Consumer Group, effective August 1, 2023. Notarainni is a seasoned, transformational leader who has served as Intuit’s Chief Customer Success Officer for the last five years, and, prior to that, served for eight years as an integral member of the Consumer Group leadership team. Notarainni led the creation of the company’s assisted tax strategy and the Intuit Virtual Expert Platform, and was instrumental in the launch of TurboTax Live, TurboTax Live Full Service, and QuickBooks Live.

“Our strategy is to transform the assisted consumer and business tax categories through the next generation of TurboTax Live and TurboTax Live Full Service, and deliver ‘better together’ experiences between TurboTax and Credit Karma,” said Sasan Goodarzi, president and CEO of Intuit. “Mark is the creator of Intuit’s AI driven virtual expert platform and has incredible passion to change the way people get their taxes done and power their prosperity to make ends meet.”

“I could not be more excited to lead the Consumer Group,” said Notarainni. “We have a winning strategy and clear priorities to fully establish TurboTax as the platform of choice for all tax filers.”

Notarainni has over 20 years’ experience in technology and customer strategy, including more than 14 years at Intuit. The current General Manager of the Consumer Group, Varun Krishna, will step down and depart the company to pursue the next chapter of his career.

About Intuit

Intuit is the global financial technology platform that powers prosperity for the people and communities we serve. With more than 100 million customers worldwide using TurboTax, Credit Karma, QuickBooks, and Mailchimp, we believe that everyone should have the opportunity to prosper. We never stop working to find new, innovative ways to make that possible. Please visit us at Intuit.com and find us on social for the latest information about Intuit and our products and services.

Rick Heineman

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Software Internet Finance Accounting Professional Services Technology Fintech Security

MEDIA:

Logo
Logo

Visa to Acquire Pismo

Visa to Acquire Pismo

SAN FRANCISCO–(BUSINESS WIRE)–
Visa (NYSE: V) today announced it has signed a definitive agreement to acquire Pismo, a cloud-native issuer processing and core banking platform with operations in Latin America, Asia Pacific and Europe, for $1 billion in cash.

By acquiring Pismo, Visa will be positioned to provide core banking and issuer processing capabilities across debit, prepaid, credit and commercial cards for clients via cloud native APIs. Pismo’s platform will also enable Visa to provide support and connectivity for emerging payment rails, like Pix in Brazil, for financial institution clients.

“Through the acquisition of Pismo, Visa can better serve our financial institution and fintech clients with more differentiated core banking and issuer solutions they can offer their customers,” said Jack Forestell, Chief Product and Strategy Officer, Visa.

“At Pismo, we aim to enable our clients to launch cutting-edge payments and banking products within a single cloud-native platform – regardless of rails, geography or currency. Visa provides us unrivalled support to expand our footprint globally and help shape a new era for banking and payments,“ said Ricardo Josua, Co-Founder, CEO, Pismo.

Pismo will retain its current management team. The transaction is subject to regulatory approvals and other customary closing conditions and is expected to close by the end of 2023.

About Visa Inc.

Visa (NYSE: V) is a world leader in digital payments, facilitating transactions between consumers, merchants, financial institutions and government entities across more than 200 countries and territories. Our mission is to connect the world through the most innovative, convenient, reliable and secure payments network, enabling individuals, businesses and economies to thrive. We believe that economies that include everyone everywhere, uplift everyone everywhere and see access as foundational to the future of money movement. Learn more at Visa.com.

About Pismo

Pismo is a technology company with deep experience developing and implementing banking and cards solutions for digital banks and large financial institutions. The company has operations in Latin America, Southeast Asia and Europe. The company’s investors include Redpoint eventures, Softbank, Amazon and Accel.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are identified by words such as “will,” “is expected,” and other similar expressions. Examples of forward-looking statements include, but are not limited to, statements we make regarding the timing and likelihood of closing, Pismo’s future success, the impact of the acquisition on Visa’s growth, and the other benefits to Visa, financial institutions and consumers.

By their nature, forward-looking statements: (i) speak only as of the date they are made; (ii) are not statements of historical fact or guarantees of future performance; and (iii) are subject to risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Therefore, actual results could differ materially and adversely from Visa’s forward-looking statements due to a variety of factors, including the timing and outcome of the regulatory approval process, shifts in the regulatory and competitive landscape, cybersecurity incidents, the pace and success of integration, and various other factors, including those contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2022, and our other filings with the U.S. Securities and Exchange Commission.

You should not place undue reliance on such statements. Except as required by law, we do not intend to update or revise any forward-looking statements as a result of new information, future developments or otherwise.

Media Contacts

Visa

Constantine Panagiotatos

[email protected]

Pismo

Debora Fortes

[email protected]

KEYWORDS: Brazil United States South America North America Latin America Asia Pacific Europe California

INDUSTRY KEYWORDS: Technology Payments Finance Fintech Banking Electronic Commerce Professional Services Digital Cash Management/Digital Assets Internet

MEDIA:

Logo
Logo

Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM

P
haxiam
Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM

Lyon (France) and Cambridge (MA, US), June 28, 2023 – Phaxiam Therapeutics (Nasdaq & Euronext: FR0011471135), announces change of the mnemonic code of its share
from
ERYP to PHXM, following the merger between ERYTECH and PHERECYDES. The change has been notified by Euronext and will be effective from June 29, 2023.

  • Company name: Phaxiam Therapeutics
  • ISIN code: FR0011471135
  • Mnemonic: PHXM
  • Listing: Euronext Paris (Compartment C) and Nasdaq

About PHAXIAM Therapeutics

PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa.

PPHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: PHXM). PHAXIAM is part of the CAC Healthcare, CAC Pharma & Bio, CAC Mid & Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotech indexes.

For more information, please visit

www.erytech.com

Contacts

PHAXIAM

Eric Soyer

COO & CFO
+33 4 78 74 44 38
[email protected]

NewCap

Mathilde Bohin / Louis-Victor Delouvrier

Relations investisseurs
Arthur Rouillé
Relations Médias
+33 1 44 71 94 94
[email protected]

 

Attachment



ImmuCell Announces Change in Timing of Anticipated FDA Submission

PORTLAND, Maine, June 28, 2023 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced a change to its anticipated FDA submission schedule.

“Although we had planned to make our next FDA submission during the second quarter of this year, we have decided to add one additional month to the projected regulatory development process for Re-Tain®,” commented Michael F. Brigham, President and CEO of ImmuCell. “The CMC Technical Section is ready for submission at this time, but we are going to use this extra time to optimize our readiness for the related pre-approval re-inspection.”


About ImmuCell:


ImmuCell Corporation’s (Nasdaq: ICCC) purpose is to create scientifically proven and practical products that improve the health and productivity of dairy and beef cattle. ImmuCell manufactures and markets First Defense®, providing Immediate Immunity™ to newborn dairy and beef calves, and is in the late stages of developing Re-Tain®, a novel treatment for subclinical mastitis in dairy cows without a milk discard requirement that provides an alternative to traditional antibiotics. Press releases and other information about the Company are available at: http://www.immucell.com.

Contacts:     Michael F. Brigham, President and CEO
ImmuCell Corporation
(207) 878-2770

Joe Diaz, Robert Blum and Joe Dorame
Lytham Partners, LLC
(602) 889-9700
[email protected]


Cautionary Note Regarding Forward-Looking Statements (Safe


Harbor


Statement):

This Press Release contains or may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements can be identified by the fact that they do not relate strictly to historical or current facts and will often include words such as “expects”, “may”, “anticipates”, “aims”, “intends”, “would”, “could”, “should”, “will”, “plans”, “believes”, “estimates”, “targets”, “projects”, “forecasts”, “seeks” and similar words and expressions. Such statements include, but are not limited to, any forward-looking statements relating to: our plans and strategies for our business; projections of future financial or operational performance; the scope and timing of ongoing and future product development work and commercialization of our products; the timing and completeness of any regulatory submissions or milestones and possible regulatory approval of any of our products (including Re-Tain®) and any other statements that are not historical facts. These statements are intended to provide management’s current expectation of future events as of the date of this Press Release, are based on management’s estimates, projections, beliefs and assumptions as of the date hereof; and are not guarantees of future performance. Such statements involve known and unknown risks and uncertainties that may cause the Company’s actual results, financial or operational performance or achievements to be materially different from those expressed or implied by these forward-looking statements, including, but not limited to, those risks and uncertainties detailed from time to time in filings we make with the Securities and Exchange Commission (SEC), including our Quarterly Reports on Form 10-Q, our Annual Reports on Form 10-K and our Current Reports on Form 8-K. In addition, there can be no assurance that future risks, uncertainties or developments affecting us will be those that we anticipate. We undertake no obligation to update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.



Epsilon Announces New Senior Secured Reserve-Based Revolving Credit Facility

HOUSTON, June 28, 2023 (GLOBE NEWSWIRE) — Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today reported the closing of a new senior secured reserve-based revolving credit facility (the “Credit Facility”) with Frost Bank as the issuing bank and sole lender. The new Credit Facility will replace the Company’s previous credit facility.

Highlights of the Credit Facility are listed below:

  • Four year term (matures June 28, 2027)
  • Initial borrowing base of $35 million, supported by the Company’s upstream assets in Pennsylvania, with semi-annual redeterminations
  • Initial commitments of $35 million
  • Interest is charged on drawdowns at the Daily Simple SOFR rate plus a margin of 3.25%, payable quarterly

“Our new credit facility includes attractive commercial terms and covenants that will enable us to flexibly deploy incremental capital to attractive opportunities within our existing asset base and potential future acquisitions, to the benefit of our shareholders,” commented Andrew Williamson, Epsilon’s Chief Financial Officer. “We remain committed to our high quality balance sheet and capital structure, and will be prudent in our use of leverage going forward. I would like to thank Frost for their confidence in our business.”


About Epsilon

Epsilon Energy Ltd. is a North American on-shore focused independent exploration and production company engaged in the acquisition, development, gathering and production of oil and gas reserves. Our primary area of operation is the Marcellus basin in Northeast Pennsylvania complemented by additional upstream assets in the Permian and Anadarko basins. For more information, please visit www.epsilonenergyltd.com, where we routinely post announcements, updates, events, investor information, presentations and recent news releases.


Forward-Looking Statements

Certain statements contained in this news release constitute forward looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, ‘may”, “will”, “project”, “should”, ‘believe”, and similar expressions are intended to identify forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated. Forward-looking statements are based on reasonable assumptions, but no assurance can be given that these expectations will prove to be correct and the forward-looking statements included in this news release should not be unduly relied upon.


Contact Information:

281-670-0002

Jason Stabell
Chief Executive Officer
[email protected]

Andrew Williamson
Chief Financial Officer
[email protected]



H.B. Fuller Reports Second Quarter 2023 Results

H.B. Fuller Reports Second Quarter 2023 Results

Net income of $40 million; Adjusted EBITDA of $143 million, at the mid-point of Company guidance

Adjusted gross profit margin expanded 330 basis points year-on-year to 29.0%

Adjusted EBITDA margin increased 190 basis points year-on-year to 15.9%

Cash flow from operations increased $94 million year-on-year

ST. PAUL, Minn.–(BUSINESS WIRE)–
H.B. Fuller Company (NYSE: FUL) today reported financial results for its second quarter that ended June 3, 2023.

Second Quarter 2023 Noteworthy Items:

  • Net revenue of $898 million, down 9.6% year-on-year; organic revenue decreased 8.3% year-on-year, driven by lower volume;

  • Gross margin was 28.6%; adjusted gross margin of 29.0% increased 330 basis points year-on-year, driven by the combined impact of pricing and raw material cost actions;

  • Net income was $40 million; adjusted EBITDA was $143 million, at the mid-point of Company guidance and up 3% year-on-year, adjusted EBITDA margin expanded 190 basis points year-on-year to 15.9%;

  • Reported EPS (diluted) was $0.73; adjusted EPS (diluted) was $0.93, down versus the prior year, driven by higher interest expense and unfavorable foreign currency exchange;

  • Cash flow from operations in the second quarter improved $94 million year-on-year to $103 million.

Summary of Second Quarter 2023 Results:

The Company’s net revenue for the second quarter of fiscal 2023 was $898 million, down 9.6% versus the second quarter of fiscal 2022. Organic revenue declined 8.3% year-on-year, driven by lower volume, offset somewhat by favorable pricing. Volume declined 14.2%, driven by customer destocking actions and generally slower industrial demand across all three global business units. Pricing actions favorably impacted organic growth by 5.9 percentage points. Foreign currency translation reduced net revenue growth by 3.4 percentage points and acquisitions increased net revenue growth by 2.1 percentage points.

Gross profit in the second quarter of fiscal 2023 was $257 million. Adjusted gross profit was $261 million. Adjusted gross profit margin of 29.0% increased 330 basis points year-on-year. Pricing and raw material cost actions and operating efficiencies drove the increase in adjusted gross margin year-on-year and more than offset the impact of lower volume.

Selling, general and administrative (SG&A) expense was $167 million in the second quarter of fiscal 2023 and adjusted SG&A was $159 million, effectively flat year-on-year, as good cost management, restructuring benefits, and favorable foreign currency impacts offset inflation in wages and services.

Net income attributable to H.B. Fuller for the second quarter of fiscal 2023 was $40 million, or $0.73 per diluted share. Adjusted net income attributable to H.B. Fuller for the second quarter of fiscal 2023 was $52 million. Adjusted EPS was $0.93 per diluted share, down year-on-year due to higher interest expense and unfavorable foreign currency impacts, which reduced diluted earnings per share by approximately $0.19 and $0.07, respectively, year-on-year in the second quarter.

Adjusted EBITDA in the second quarter of fiscal 2023 was $143 million, at the mid-point of Company guidance and up 3% year-on-year. Adjusted EBITDA margin increased 190 basis points year-on-year to 15.9%, driven by the combined impact of pricing and raw material cost actions versus the prior year’s second quarter, as well as restructuring savings, partially offset by the impacts of lower volume and wage and other inflation.

“Pricing discipline and focused efforts to reduce costs drove margin expansion and overcame a challenging volume environment, delivering second quarter profit performance in-line with our expectations,” said Celeste Mastin, H.B. Fuller president and chief executive officer. “Our ability to successfully manage changing price and raw material dynamics, and scale production costs with volume, is delivering EBITDA growth and significant margin improvement. We remain on track to deliver strong growth in adjusted EBITDA and outstanding cash flow in fiscal 2023.

“Global industrial activity has slowed, but underlying demand across the portfolio remains much stronger than our second quarter volume performance implies, due to the effect of customer destocking, which is significant, but not unique to us, or our industry. This destocking is now tapering over a large portion of our portfolio, and we believe our year-on-year volume comparisons will be stronger in the second half of the year.

“Our diverse portfolio and robust innovation pipeline engender continual product line upgrades that solve customer problems, enabling strong profit growth in almost any economic environment. Our confidence remains high in a stronger second half performance as we expect customer destocking activities to fade, EBITDA margins to continue to expand due to price and raw material cost management, demand in China to improve, better foreign currency comparisons, and restructuring benefits to ramp through the end of the year.”

Balance Sheet and Cash Flow Items:

Net debt at the end of the second quarter of fiscal 2023 was $1,779 million, up $31 million sequentially versus the first quarter and down $89 million year-on-year. The sequential increase in net debt was driven by acquisition activity during the second quarter, offset by improved cash flow from operations.

Cash flow from operations in the second quarter was $103 million, up $94 million year-on-year, reflecting improving margins and lower net working capital requirements.

Fiscal 2023 Outlook:

  • Adjusted EBITDA for fiscal 2023 is still expected to be in the range of $580 million to $610 million, equating to growth of approximately 9% to 15% versus fiscal year 2022;

  • Both net revenue and organic revenue for fiscal 2023 are now expected to be down 3% to 5% versus fiscal 2022, reflecting continued customer destocking actions and slower industrial production; the combined impact of FX, acquisitions, and the extra week in fiscal 2022 are expected to be effectively neutral versus fiscal 2023;

  • Net interest expense is now expected to be in the range of $125 million to $135 million and depreciation and amortization expense is expected to be approximately $160 million, reflecting recent acquisition activity and higher interest rates;

  • Adjusted EPS (diluted) is now expected to be in the range of $3.80 to $4.20, equating to a range of down 5% to up 5% year-on-year;

  • Operating cash flow in fiscal 2023 is now expected to be between $325 million and $375 million.

Conference Call:

The Company will hold a conference call on June 29, 2023, at 9:30 a.m. CT (10:30 a.m. ET) to discuss its results. Interested parties may listen to the conference call on a live webcast. The webcast, along with a supplemental presentation, may be accessed from the Company’s website at https://investors.hbfuller.com. Participants must register prior to accessing the webcast using this link and should do so at least 10 minutes prior to the start of the call to install and test any necessary software and audio connections. A telephone replay of the conference call will be available from 12:30 p.m. CT on June 29, 2023, to 10:59 p.m. CT on July 6, 2023. To access the telephone replay dial 1-800-770-2030 (toll free) or 1-647-362-9199, and enter Conference ID: 6370505.

Regulation G

The information presented in this earnings release regarding consolidated and segment organic revenue growth, operating income, adjusted gross profit, adjusted gross profit margin, adjusted selling, general and administrative expense, adjusted income before income taxes and income from equity investments, adjusted income taxes, adjusted effective tax rate, adjusted net income, adjusted diluted earnings per share and adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) does not conform to U.S. generally accepted accounting principles (U.S. GAAP) and should not be construed as an alternative to the reported results determined in accordance with U.S. GAAP. Management has included this non-GAAP information to assist in understanding the operating performance of the Company and its operating segments as well as the comparability of results to the results of other companies. The non-GAAP information provided may not be consistent with the methodologies used by other companies. All non-GAAP information is reconciled with reported U.S. GAAP results in the “Regulation G Reconciliation” tables in this press release with the exception of our forward-looking non-GAAP measures contained above in our Fiscal 2023 Outlook, which the Company cannot reconcile to forward-looking GAAP results without unreasonable effort.

About H.B. Fuller

Since 1887, H.B. Fuller has been a leading global adhesives provider focusing on perfecting adhesives and sealants to improve products and lives. With fiscal 2022 net revenue of $3.75 billion, H.B. Fuller’s commitment to innovation and sustainable adhesive solutions brings together people, products and processes that answer and solve some of the world’s biggest challenges. Our reliable, responsive service creates lasting, rewarding connections with customers in electronics, disposable hygiene, medical, transportation, aerospace, clean energy, packaging, construction, woodworking, general industries and other consumer businesses. Our promise to our people connects them with opportunities to innovate and thrive. For more information, visit us at https://www.hbfuller.com.

Safe Harbor for Forward-Looking Statements

Certain statements in this press release may be considered forward-looking statements within the meaning of the federal securities laws, including Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements often address expected future business and financial performance, financial condition, and other matters, and often contain words or phrases such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “opportunity,” “outlook,” “plan,” “project,” “seek,” “should,” “strategy,” “target,” “will,” “will be,” “will continue,” “will likely result,” “would” and similar expressions, and variations or negatives of these words or phrases. These statements are subject to various risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including but not limited to the following: the consequences of the COVID-19 outbreak and other pandemics on our operations and financial results; the impact on the supply chain, raw material costs and pricing of our products due to the Russia-Ukraine war; the impact on our margins and product demand due to inflationary pressures; the substantial amount of debt we have incurred to finance our acquisition of Royal, our ability to repay or refinance our debt or to incur additional debt in the future, our need for a significant amount of cash to service and repay the debt and to pay dividends on our common stock, the effect of debt covenants that limit the discretion of management in operating the business or in paying dividends; our ability to pay dividends and to pursue growth opportunities if we continue to pay dividends according to the current dividend policy; our ability to achieve expected synergies, cost savings and operating efficiencies from our restructuring initiatives and operational improvement projects within the expected time frames or at all; our ability to effectively implement Project ONE; uncertain political and economic conditions; fluctuations in product demand; competing products and pricing; our geographic and product mix; availability and price of raw materials; disruptions to our relationships with our major customers and suppliers; failures in our information technology systems; regulatory compliance across our global footprint; trade policies and economic sanctions impacting our markets; changes in tax laws and tariffs; devaluations and other foreign exchange rate fluctuations; the impact of litigation and investigations, including for product liability and environmental matters; impairment charges on our goodwill or long-lived assets; the effect of new accounting pronouncements and accounting charges and credits; and similar matters.

Additional information about these various risks and uncertainties can be found in the “Risk Factors” section of our Form 10-K filings, and any updates to the risk factors in our Form 10-Q and 8-K filings with the SEC, but there may be other risks and uncertainties that we are unable to identify at this time or that we do not currently expect to have a material impact on the business. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. We do not undertake to update or revise any forward-looking statements, except as required by law.

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED FINANCIAL INFORMATION

In thousands, except per share amounts (unaudited)

 

 

Three Months

Ended

 

 

Percent of

 

 

Three Months

Ended

 

 

Percent of

 

 

 

June 3, 2023

 

 

Net Revenue

 

 

May 28, 2022

 

 

Net Revenue

 

Net revenue

 

$

898,239

 

 

 

100.0

%

 

$

993,258

 

 

 

100.0

%

Cost of sales

 

 

(641,464

)

 

 

(71.4

)%

 

 

(739,737

)

 

 

(74.5

)%

Gross profit

 

 

256,775

 

 

 

28.6

%

 

 

253,521

 

 

 

25.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

(166,625

)

 

 

(18.6

)%

 

 

(166,007

)

 

 

(16.7

)%

Other income, net

 

 

605

 

 

 

0.1

%

 

 

 

 

 

0.0

%

Interest expense

 

 

(33,131

)

 

 

(3.7

)%

 

 

(19,828

)

 

 

(2.0

)%

Interest income

 

 

932

 

 

 

0.1

%

 

 

2,091

 

 

 

0.2

%

Income before income taxes and income from equity method investments

 

 

58,556

 

 

 

6.5

%

 

 

69,777

 

 

 

7.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

 

(19,291

)

 

 

(2.1

)%

 

 

(23,616

)

 

 

(2.4

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from equity method investments

 

 

1,157

 

 

 

0.1

%

 

 

1,066

 

 

 

0.1

%

Net income including non-controlling interest

 

 

40,422

 

 

 

4.5

%

 

 

47,227

 

 

 

4.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to non-controlling interest

 

 

(21

)

 

 

(0.0

)%

 

 

(24

)

 

 

(0.0

)%

Net income attributable to H.B. Fuller

 

$

40,401

 

 

 

4.5

%

 

$

47,203

 

 

 

4.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income per common share attributable to H.B. Fuller

 

$

0.74

 

 

 

 

 

 

$

0.88

 

 

 

 

 

Diluted income per common share attributable to H.B. Fuller

 

$

0.73

 

 

 

 

 

 

$

0.86

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

54,269

 

 

 

 

 

 

 

53,497

 

 

 

 

 

Diluted

 

 

55,717

 

 

 

 

 

 

 

55,078

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per common share

 

$

0.205

 

 

 

 

 

 

$

0.190

 

 

 

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

CONSOLIDATED FINANCIAL INFORMATION

In thousands, except per share amounts (unaudited)

 

 

Six Months

Ended

 

 

Percent of

 

 

Six Months

Ended

 

 

Percent of

 

 

 

June 3, 2023

 

 

Net Revenue

 

 

May 28, 2022

 

 

Net Revenue

 

Net revenue

 

$

1,707,421

 

 

 

100.0

%

 

$

1,849,739

 

 

 

100.0

%

Cost of sales

 

 

(1,235,838

)

 

 

(72.4

)%

 

 

(1,383,326

)

 

 

(74.8

)%

Gross profit

 

 

471,583

 

 

 

27.6

%

 

 

466,413

 

 

 

25.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

(321,167

)

 

 

(18.8

)%

 

 

(321,898

)

 

 

(17.4

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other income, net

 

 

3,209

 

 

 

0.2

%

 

 

6,142

 

 

 

0.3

%

Interest expense

 

 

(66,200

)

 

 

(3.9

)%

 

 

(38,025

)

 

 

(2.1

)%

Interest income

 

 

1,599

 

 

 

0.1

%

 

 

4,030

 

 

 

0.2

%

Income before income taxes and income from equity method investments

 

 

89,024

 

 

 

5.2

%

 

 

116,662

 

 

 

6.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income taxes

 

 

(29,024

)

 

 

(1.7

)%

 

 

(33,765

)

 

 

(1.8

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from equity method investments

 

 

2,338

 

 

 

0.1

%

 

 

2,649

 

 

 

0.1

%

Net income including non-controlling interest

 

 

62,338

 

 

 

3.7

%

 

 

85,546

 

 

 

4.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to non-controlling interest

 

 

(48

)

 

 

(0.0

)%

 

 

(37

)

 

 

(0.0

)%

Net income attributable to H.B. Fuller

 

$

62,290

 

 

 

3.6

%

 

$

85,509

 

 

 

4.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic income per common share attributable to H.B. Fuller

 

$

1.15

 

 

 

 

 

 

$

1.60

 

 

 

 

 

Diluted income per common share attributable to H.B. Fuller

 

$

1.12

 

 

 

 

 

 

$

1.55

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

54,222

 

 

 

 

 

 

 

53,425

 

 

 

 

 

Diluted

 

 

55,818

 

 

 

 

 

 

 

55,237

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividends declared per common share

 

$

0.395

 

 

 

 

 

 

$

0.358

 

 

 

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 3,

 

 

May 28,

 

 

June 3,

 

 

May 28,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to H.B. Fuller

 

$

40,401

 

 

$

47,203

 

 

$

62,290

 

 

$

85,509

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition project costs1

 

 

2,919

 

 

 

2,014

 

 

 

5,154

 

 

 

7,871

 

Organizational realignment2

 

 

5,690

 

 

 

2,818

 

 

 

8,634

 

 

 

4,446

 

Royal restructuring and integration3

 

 

 

 

 

412

 

 

 

 

 

 

810

 

Project One

 

 

2,681

 

 

 

1,853

 

 

 

4,853

 

 

 

5,057

 

Other4

 

 

521

 

 

 

6,264

 

 

 

3,594

 

 

 

7,430

 

Discrete tax items5

 

 

2,042

 

 

 

4,149

 

 

 

2,888

 

 

 

1,248

 

Income tax effect on adjustments6

 

 

(2,172

)

 

 

(3,526

)

 

 

(4,572

)

 

 

(7,035

)

Adjusted net income attributable to H.B. Fuller7

 

 

52,082

 

 

 

61,187

 

 

 

82,841

 

 

 

105,336

 

Add:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense

 

 

33,131

 

 

 

19,841

 

 

 

63,511

 

 

 

38,051

 

Interest income

 

 

(932

)

 

 

(2,091

)

 

 

(1,599

)

 

 

(4,041

)

Adjusted Income taxes

 

 

19,421

 

 

 

22,993

 

 

 

30,707

 

 

 

39,552

 

Depreciation and Amortization expense8

 

 

39,063

 

 

 

36,637

 

 

 

76,976

 

 

 

72,434

 

Adjusted EBITDA7

 

 

142,765

 

 

 

138,567

 

 

 

252,436

 

 

 

251,332

 

Diluted Shares

 

 

55,717

 

 

 

55,078

 

 

 

55,818

 

 

 

55,237

 

Adjusted diluted income per common share attributable to H.B. Fuller7

 

$

0.93

 

 

$

1.11

 

 

$

1.48

 

 

$

1.91

 

Revenue

 

$

898,239

 

 

$

993,258

 

 

$

1,707,421

 

 

$

1,849,739

 

Adjusted EBITDA margin7

 

 

15.9

%

 

 

14.0

%

 

 

14.8

%

 

 

13.6

%

1 Acquisition project costs include costs related to integrating and accounting for acquisitions.

2 Organizational realignment includes costs incurred as a direct result of the organizational realignment program announced in 2023, including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities.

3 Royal restructuring and integration program includes costs incurred as a direct result of the Royal restructuring and integration program including compensation for employees supporting the program, consulting expense and operational inefficiencies related to the closure of production facilities and consolidation of business activities.

4 For fiscal 2023, Other expenses include write-off of unamortized debt fees and non-cash gains and losses related to legal entity consolidations. For fiscal 2022, other expenses include a non-cash charge related to wind down and settlement of the Company’s Canadian defined benefit pension plan, hedging costs related to the Russian ruble devaluation driven by the war in Ukraine, transactional tax expense associated with an audit settlement, other expenses for COVID-19 testing, vaccinations, and exceptional medical claims, and non-cash gains and losses related to legal entity consolidations.

5 Discrete tax items for the current year are related to various foreign tax matters offset by an excess tax benefit related to U.S. stock compensation. Discrete tax items for the prior year are related to the revaluation of cross-currency swap agreements due to depreciation of the Euro versus the U.S. Dollar, as well as various foreign tax matters offset by the tax effect of legal entity mergers.

6 Income tax effect on adjustments represents the difference between income taxes on net income before income taxes and income from equity method investments reported in accordance with U.S. GAAP and adjusted net income before income taxes and income from equity method investments.

7 Adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin are non-GAAP financial measures. Adjusted net income attributable to H.B. Fuller is defined as net income before the specific adjustments shown above. Adjusted diluted income per common share is defined as adjusted net income attributable to H.B. Fuller divided by the number of diluted common shares. Adjusted EBITDA is defined as net income before interest, income taxes, depreciation, amortization and the specific adjustments shown above. Adjusted EBITDA margin is defined as adjusted EBITDA divided by net revenue. The table above provides a reconciliation of adjusted net income attributable to H.B. Fuller, adjusted diluted income per common share attributable to H.B. Fuller, adjusted EBITDA and adjusted EBITDA margin to net income attributable to H.B. Fuller, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

8 Depreciation and amortization expense added back for EBITDA is adjusted for amounts already included in adjusted net income attributable to H.B. Fuller totaling $18 and ($153) for the three months ended June 3, 2023 and May 28, 2022, respectively and $0 and ($311) for the six months ended June 3, 2023 and May 28, 2022, respectively.

H.B. FULLER COMPANY AND SUBSIDIARIES

SEGMENT FINANCIAL INFORMATION

In thousands (unaudited)

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 3,

 

 

May 28,

 

 

June 3,

 

 

May 28,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hygiene, Health and Consumable Adhesives

 

$

404,486

 

 

$

437,889

 

 

$

788,014

 

 

$

827,427

 

Engineering Adhesives

 

 

364,080

 

 

 

405,346

 

 

 

697,147

 

 

 

759,323

 

Construction Adhesives

 

 

129,673

 

 

 

150,023

 

 

 

222,260

 

 

 

262,989

 

Corporate unallocated

 

 

 

 

 

 

 

 

 

 

 

 

Total H.B. Fuller

 

$

898,239

 

 

$

993,258

 

 

$

1,707,421

 

 

$

1,849,739

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Segment Operating Income (Loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hygiene, Health and Consumable Adhesives

 

$

51,592

 

 

$

43,267

 

 

$

96,738

 

 

$

75,480

 

Engineering Adhesives

 

 

44,400

 

 

 

42,917

 

 

 

76,875

 

 

 

75,489

 

Construction Adhesives

 

 

5,969

 

 

 

11,285

 

 

 

(3,664

)

 

 

15,641

 

Corporate unallocated

 

 

(11,811

)

 

 

(9,955

)

 

 

(19,533

)

 

 

(22,095

)

Total H.B. Fuller

 

$

90,150

 

 

$

87,514

 

 

$

150,416

 

 

$

144,515

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hygiene, Health and Consumable Adhesives

 

$

65,234

 

 

$

57,872

 

 

$

124,953

 

 

$

104,470

 

Engineering Adhesives

 

 

61,159

 

 

 

59,520

 

 

 

111,035

 

 

 

109,399

 

Construction Adhesives

 

 

18,221

 

 

 

24,121

 

 

 

21,065

 

 

 

39,998

 

Corporate unallocated

 

 

(1,849

)

 

 

(2,946

)

 

 

(4,617

)

 

 

(2,535

)

Total H.B. Fuller

 

$

142,765

 

 

$

138,567

 

 

$

252,436

 

 

$

251,332

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted EBITDA Margin7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hygiene, Health and Consumable Adhesives

 

 

16.1

%

 

 

13.2

%

 

 

15.9

%

 

 

12.6

%

Engineering Adhesives

 

 

16.8

%

 

 

14.7

%

 

 

15.9

%

 

 

14.4

%

Construction Adhesives

 

 

14.1

%

 

 

16.1

%

 

 

9.5

%

 

 

15.2

%

Corporate unallocated

 

NMP

 

 

NMP

 

 

NMP

 

 

NMP

 

Total H.B. Fuller

 

 

15.9

%

 

 

14.0

%

 

 

14.8

%

 

 

13.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NMP = non-meaningful percentage

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 3,

 

 

May 28,

 

 

June 3,

 

 

May 28,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Income before income taxes and income from equity method investments

 

$

58,556

 

 

$

69,777

 

 

$

89,024

 

 

$

116,662

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition project costs1

 

 

2,919

 

 

 

2,014

 

 

 

5,154

 

 

 

7,871

 

Organizational realignment2

 

 

5,690

 

 

 

2,818

 

 

 

8,634

 

 

 

4,446

 

Royal restructuring and integration3

 

 

 

 

 

412

 

 

 

 

 

 

810

 

Project One

 

 

2,681

 

 

 

1,853

 

 

 

4,853

 

 

 

5,057

 

Other4

 

 

521

 

 

 

6,264

 

 

 

3,594

 

 

 

7,430

 

Adjusted income before income taxes and income from equity method investments9

 

$

70,367

 

 

$

83,138

 

 

$

111,259

 

 

$

142,276

 

9 Adjusted income before income taxes and income from equity investments is a non-GAAP financial measure. Adjusted income before income taxes and income from equity investments is defined as income before income taxes and income from equity investments before the specific adjustments shown above. The table above provides a reconciliation of adjusted income before income taxes and income from equity investments to income before income taxes and income from equity investments, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands, except per share amounts (unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 3,

 

 

May 28,

 

 

June 3,

 

 

May 28,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Income Taxes

 

$

(19,291

)

 

$

(23,616

)

 

$

(29,024

)

 

$

(33,765

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition project costs1

 

 

(537

)

 

 

(531

)

 

 

(1,051

)

 

 

(2,209

)

Organizational realignment2

 

 

(1,046

)

 

 

(744

)

 

 

(1,724

)

 

 

(1,210

)

Royal restructuring and integration3

 

 

 

 

 

(109

)

 

 

 

 

 

(223

)

Project One

 

 

(493

)

 

 

(489

)

 

 

(993

)

 

 

(1,406

)

Other4

 

 

1,946

 

 

 

2,496

 

 

 

2,085

 

 

 

(739

)

Adjusted income taxes10

 

$

(19,421

)

 

$

(22,993

)

 

$

(30,707

)

 

$

(39,552

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjusted income before income taxes and income from equity method investments

 

$

70,367

 

 

$

83,138

 

 

$

111,259

 

 

$

142,276

 

Adjusted effective income tax rate10

 

 

27.6

%

 

 

27.7

%

 

 

27.6

%

 

 

27.8

%

10 Adjusted income taxes and adjusted effective income tax rate are non-GAAP financial measures. Adjusted income taxes is defined as income taxes before the specific adjustments shown above. Adjusted effective income tax rate is defined as income taxes divided by adjusted income before income taxes and income from equity method investments. The table above provides a reconciliation of adjusted income taxes and adjusted effective income tax rate to income taxes, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 3,

 

 

May 28,

 

 

June 3,

 

 

May 28,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net revenue

 

$

898,239

 

 

$

993,258

 

 

$

1,707,421

 

 

$

1,849,739

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gross profit

 

$

256,775

 

 

$

253,521

 

 

$

471,583

 

 

$

466,413

 

Gross profit margin

 

 

28.6

%

 

 

25.5

%

 

 

27.6

%

 

 

25.2

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition project costs1

 

 

1,058

 

 

 

(238

)

 

 

1,101

 

 

 

424

 

Organizational realignment2

 

 

2,690

 

 

 

1,520

 

 

 

5,011

 

 

 

1,783

 

Royal restructuring and integration3

 

 

 

 

 

140

 

 

 

 

 

 

372

 

Project ONE

 

 

 

 

 

6

 

 

 

 

 

 

6

 

Other4

 

 

53

 

 

 

447

 

 

 

160

 

 

 

825

 

Adjusted gross profit11

 

$

260,576

 

 

$

255,396

 

 

$

477,855

 

 

$

469,823

 

Adjusted gross profit margin11

 

 

29.0

%

 

 

25.7

%

 

 

28.0

%

 

 

25.4

%

11 Adjusted gross profit and adjusted gross profit margin are non-GAAP financial measures. Adjusted gross profit and adjusted gross profit margin is defined as gross profit and gross profit margin excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted gross profit and adjusted gross profit margin to gross profit and gross profit margin, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 3,

 

 

May 28,

 

 

June 3,

 

 

May 28,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

$

(166,625

)

 

$

(166,007

)

 

$

(321,167

)

 

$

(321,898

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Acquisition project costs1

 

 

1,861

 

 

 

2,252

 

 

 

4,053

 

 

 

7,447

 

Organizational realignment2

 

 

3,000

 

 

 

2,275

 

 

 

3,623

 

 

 

3,630

 

Royal restructuring and integration3

 

 

 

 

 

286

 

 

 

 

 

 

464

 

Project ONE

 

 

2,681

 

 

 

1,847

 

 

 

4,853

 

 

 

5,051

 

Other4

 

 

468

 

 

 

1,421

 

 

 

731

 

 

 

2,094

 

Adjusted selling, general and administrative expenses12

 

$

(158,615

)

 

$

(157,926

)

 

$

(307,907

)

 

$

(303,212

)

12 Adjusted selling, general and administrative expenses is a non-GAAP financial measure. Adjusted selling, general and administrative expenses is defined as selling, general and administrative expenses excluding the specific adjustments shown above. The table above provides a reconciliation of adjusted selling, general and administrative expenses to selling, general and administrative expenses, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

Three Months Ended

Hygiene, Health and Consumable

 

Engineering

 

Construction

 

 

 

Corporate

 

H.B. Fuller

June 3, 2023

Adhesives

 

Adhesives

 

Adhesives

 

Total

 

Unallocated

 

Consolidated

Net income attributable to H.B. Fuller

$

52,692

 

$

45,172

 

$

7,687

 

$

105,551

 

$

(65,150

)

$

40,401

 

Adjustments:

 

 

 

 

 

 

Acquisition project costs1

 

 

 

 

 

 

 

 

 

2,919

 

 

2,919

 

Organizational realignment2

 

 

 

 

 

 

 

 

 

5,690

 

 

5,690

 

Royal Restructuring and integration3

 

 

 

 

 

 

 

 

 

 

 

 

Project One

 

 

 

 

 

 

 

 

 

2,681

 

 

2,681

 

Other4

 

 

 

 

 

 

 

 

 

521

 

 

521

 

Discrete tax items5

 

 

 

 

 

 

 

 

 

2,042

 

 

2,042

 

Income tax effect on adjustments6

 

 

 

 

 

 

 

 

 

(2,172

)

 

(2,172

)

Adjusted net income attributable to H.B. Fuller7

 

52,692

 

 

45,172

 

 

7,687

 

 

105,551

 

 

(53,469

)

 

52,082

 

Add:

 

 

 

 

 

 

Interest expense

 

 

 

 

 

 

 

 

 

33,131

 

 

33,131

 

Interest income

 

 

 

 

 

 

 

 

 

(932

)

 

(932

)

Adjusted Income taxes

 

 

 

 

 

 

 

 

 

19,421

 

 

19,421

 

Depreciation and amortization expense8

 

12,542

 

 

15,987

 

 

10,534

 

 

39,063

 

 

 

 

39,063

 

Adjusted EBITDA7

$

65,234

 

$

61,159

 

$

18,221

 

$

144,614

 

$

(1,849

)

$

142,765

 

Revenue

$

404,486

 

$

364,080

 

$

129,673

 

$

898,239

 

 

 

$

898,239

 

Adjusted EBITDA Margin7

 

16.1

%

 

16.8

%

 

14.1

%

 

16.1

%

NMP

 

15.9

%

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

June 3, 2023

 

 

 

 

 

 

Net income attributable to H.B. Fuller

$

100,399

 

$

79,522

 

$

156

 

$

180,077

 

$

(117,787

)

$

62,290

 

Adjustments:

 

 

 

 

 

 

Acquisition project costs1

 

 

 

 

 

 

 

 

 

5,154

 

 

5,154

 

Organizational realignment2

 

 

 

 

 

 

 

 

 

8,634

 

 

8,634

 

Royal Restructuring and integration3

 

 

 

 

 

 

 

 

 

 

 

 

Project One

 

 

 

 

 

 

 

 

 

4,853

 

 

4,853

 

Other4

 

 

 

 

 

 

 

 

 

3,594

 

 

3,594

 

Discrete tax items5

 

 

 

 

 

 

 

 

 

2,888

 

 

2,888

 

Income tax effect on adjustments6

 

 

 

 

 

 

 

 

 

(4,572

)

 

(4,572

)

Adjusted net income attributable to H.B. Fuller7

 

100,399

 

 

79,522

 

 

156

 

 

180,077

 

 

(97,236

)

 

82,841

 

Add:

 

 

 

 

 

 

Interest expense

 

 

 

 

 

 

 

 

 

63,511

 

 

63,511

 

Interest income

 

 

 

 

 

 

 

 

 

(1,599

)

 

(1,599

)

Adjusted Income taxes

 

 

 

 

 

 

 

 

 

30,707

 

 

30,707

 

Depreciation and amortization expense8

 

24,554

 

 

31,513

 

 

20,909

 

 

76,976

 

 

 

 

76,976

 

Adjusted EBITDA7

$

124,953

 

$

111,035

 

$

21,065

 

$

257,053

 

$

(4,617

)

$

252,436

 

Revenue

 

788,014

 

 

697,147

 

 

222,260

 

 

1,707,421

 

 

 

 

1,707,421

 

Adjusted EBITDA Margin7

 

15.9

%

 

15.9

%

 

9.5

%

 

15.1

%

NMP

 

14.8

%

Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

NMP = Non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

REGULATION G RECONCILIATION

In thousands (unaudited)

Three Months Ended

Hygiene, Health and Consumable

Engineering

Construction

 

 

Corporate

 

H.B. Fuller

May 28, 2022

Adhesives

Adhesives

Adhesives

Total

 

Unallocated

 

Consolidated

Net income attributable to H.B. Fuller

$

46,186

 

$

45,077

 

$

13,613

 

$

104,876

 

$

(57,673

)

$

47,203

 

Adjustments:

 

 

 

 

 

 

 

 

Acquisition project costs1

 

 

 

 

 

 

 

 

 

2,014

 

 

2,014

 

Organizational realignment2

 

 

 

 

 

 

 

 

 

2,818

 

 

2,818

 

Royal Restructuring and integration3

 

 

 

 

 

 

 

 

 

412

 

 

412

 

Project One

 

 

 

 

 

 

 

 

 

1,853

 

 

1,853

 

Other4

 

 

 

 

 

 

 

 

 

6,264

 

 

6,264

 

Discrete tax items5

 

 

 

 

 

 

 

 

 

4,149

 

 

4,149

 

Income tax effect on adjustments6

 

 

 

 

 

 

 

 

 

(3,526

)

 

(3,526

)

Adjusted net income attributable to H.B. Fuller7

 

46,186

 

 

45,077

 

 

13,613

 

 

104,876

 

 

(43,689

)

 

61,187

 

Add:

 

 

 

 

 

 

 

 

Interest expense

 

 

 

 

 

 

 

 

 

19,841

 

 

19,841

 

Interest income

 

 

 

 

 

 

 

 

 

(2,091

)

 

(2,091

)

Adjusted Income taxes

 

 

 

 

 

 

 

 

 

22,993

 

 

22,993

 

Depreciation and amortization expense8

 

11,686

 

 

14,443

 

 

10,508

 

 

36,637

 

 

 

 

36,637

 

Adjusted EBITDA7

$

57,872

 

$

59,520

 

$

24,121

 

$

141,513

 

$

(2,946

)

$

138,567

 

Revenue

$

437,889

 

$

405,346

 

$

150,023

 

$

993,258

 

 

 

$

993,258

 

Adjusted EBITDA Margin7

 

13.2

%

 

14.7

%

 

16.1

%

 

14.2

%

NMP

 

14.0

%

 

 

 

 

 

 

 

Six Months Ended

 

 

 

 

 

 

 

May 28, 2022

 

 

 

 

 

 

 

Net income attributable to H.B. Fuller

$

81,323

 

$

79,814

 

$

20,296

 

$

181,433

 

$

(95,924

)

$

85,509

 

Adjustments:

 

 

 

 

 

 

 

Acquisition project costs1

 

 

 

 

 

 

 

 

 

7,871

 

 

7,871

 

Organizational realignment2

 

 

 

 

 

 

 

 

 

4,446

 

 

4,446

 

Royal Restructuring and integration3

 

 

 

 

 

 

 

 

 

810

 

 

810

 

Project One

 

 

 

 

 

 

 

 

 

5,057

 

 

5,057

 

Other4

 

 

 

 

 

 

 

 

 

7,430

 

 

7,430

 

Discrete tax items5

 

 

 

 

 

 

 

 

 

1,248

 

 

1,248

 

Income tax effect on adjustments6

 

 

 

 

 

 

 

 

 

(7,035

)

 

(7,035

)

Adjusted net income attributable to H.B. Fuller7

 

81,323

 

 

79,814

 

 

20,296

 

 

181,433

 

 

(76,097

)

 

105,336

 

Add:

 

 

 

 

 

 

 

Interest expense

 

 

 

 

 

 

 

 

 

38,051

 

 

38,051

 

Interest income

 

 

 

 

 

 

 

 

 

(4,041

)

 

(4,041

)

Adjusted Income taxes

 

 

 

 

 

 

 

 

 

39,552

 

 

39,552

 

Depreciation and amortization expense8

 

23,147

 

 

29,585

 

 

19,702

 

 

72,434

 

 

 

 

72,434

 

Adjusted EBITDA7

$

104,470

 

$

109,399

 

$

39,998

 

$

253,867

 

$

(2,535

)

$

251,332

 

Revenue

$

827,427

 

$

759,323

 

$

262,989

 

$

1,849,739

 

 

 

$

1,849,739

 

Adjusted EBITDA Margin7

 

12.6

%

 

14.4

%

 

15.2

%

 

13.7

%

NMP

 

13.6

%

Note: Adjusted EBITDA is a non-GAAP financial measure. The table above provides a reconciliation of adjusted EBITDA for each segment to net income attributable to H.B. Fuller for each segment, the most directly comparable financial measure determined and reported in accordance with U.S. GAAP.

NMP = Non-meaningful percentage

H.B. FULLER COMPANY AND SUBSIDIARIES

SEGMENT FINANCIAL INFORMATION

NET REVENUE GROWTH (DECLINE)

(unaudited)

 

 

Three Months Ended

 

 

Six Months Ended

 

 

 

June 3, 2023

 

 

June 3, 2023

 

Price

 

 

5.9

%

 

 

7.0

%

Volume

 

 

(14.2

)%

 

 

(12.6

)%

Organic Growth13

 

 

(8.3

)%

 

 

(5.6

)%

M&A

 

 

2.1

%

 

 

2.0

%

Constant currency

 

 

(6.2

)%

 

 

(3.6

)%

F/X

 

 

(3.4

)%

 

 

(4.1

)%

Total H.B. Fuller Net Revenue Decline

 

 

(9.6

)%

 

 

(7.7

)%

Revenue growth versus 2022

 

Three Months Ended

 

 

 

June 3, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Constant

 

 

 

 

 

Organic

 

 

Net Revenue

 

F/X

 

Currency

 

M&A

 

Growth13

Hygiene, Health and Consumable Adhesives

 

 

(7.6

)%

 

 

(4.8

)%

 

 

(2.8

)%

 

 

2.7

%

 

 

(5.5

)%

Engineering Adhesives

 

 

(10.2

)%

 

 

(2.8

)%

 

 

(7.4

)%

 

 

1.6

%

 

 

(9.0

)%

Construction Adhesives

 

 

(13.6

)%

 

 

(1.1

)%

 

 

(12.5

)%

 

 

1.7

%

 

 

(14.2

)%

Total H.B. Fuller

 

 

(9.6

)%

 

 

(3.4

)%

 

 

(6.2

)%

 

 

2.1

%

 

 

(8.3

)%

Revenue growth versus 2022

 

Six Months Ended

 

 

 

June 3, 2023

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Constant

 

 

 

 

 

Organic

 

 

Net Revenue

 

F/X

 

Currency

 

M&A

Growth13

Hygiene, Health and Consumable Adhesives

 

 

(4.8

)%

 

 

(5.5

)%

 

 

0.7

%

 

 

1.5

%

 

 

(0.8

)%

Engineering Adhesives

 

 

(8.2

)%

 

 

(3.6

)%

 

 

(4.6

)%

 

 

1.5

%

 

 

(6.1

)%

Construction Adhesives

 

 

(15.5

)%

 

 

(1.3

)%

 

 

(14.2

)%

 

 

5.0

%

 

 

(19.2

)%

Total H.B. Fuller

 

 

(7.7

)%

 

 

(4.1

)%

 

 

(3.6

)%

 

 

2.0

%

 

 

(5.6

)%

13 We use the term “organic revenue” to refer to net revenue, excluding the effect of foreign currency changes and acquisitions and divestitures. Organic growth reflects adjustments for the impact of period-over-period changes in foreign currency exchange rates on revenues and the revenues associated with acquisitions and divestitures.

CONSOLIDATED BALANCE SHEETS

H.B. Fuller Company and Subsidiaries

(In thousands, except share and per share amounts)

 

 

June 3,

 

 

December 3,

 

 

 

2023

 

 

2022

 

Assets

 

 

 

 

 

 

 

 

Current assets:

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

103,183

 

 

$

79,910

 

Trade receivables (net of allowances of $11,512 and $10,939, as of June 3, 2023 and December 3, 2022, respectively)

 

 

586,609

 

 

 

607,365

 

Inventories

 

 

499,275

 

 

 

491,781

 

Other current assets

 

 

128,885

 

 

 

120,319

 

Total current assets

 

 

1,317,952

 

 

 

1,299,375

 

 

 

 

 

 

 

 

 

 

Property, plant and equipment

 

 

1,673,871

 

 

 

1,579,738

 

Accumulated depreciation

 

 

(886,459

)

 

 

(846,071

)

Property, plant and equipment, net

 

 

787,412

 

 

 

733,667

 

 

 

 

 

 

 

 

 

 

Goodwill

 

 

1,441,414

 

 

 

1,392,627

 

Other intangibles, net

 

 

721,564

 

 

 

702,092

 

Other assets

 

 

349,705

 

 

 

335,868

 

Total assets

 

$

4,618,047

 

 

$

4,463,629

 

 

 

 

 

 

 

 

 

 

Liabilities, non-controlling interest and total equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Notes payable

 

$

30,307

 

 

$

28,860

 

Trade payables

 

 

436,376

 

 

 

460,669

 

Accrued compensation

 

 

66,749

 

 

 

108,328

 

Income taxes payable

 

 

28,229

 

 

 

18,530

 

Other accrued expenses

 

 

99,171

 

 

 

89,345

 

Total current liabilities

 

 

660,832

 

 

 

705,732

 

 

 

 

 

 

 

 

 

 

Long-term debt

 

 

1,852,036

 

 

 

1,736,256

 

Accrued pension liabilities

 

 

53,546

 

 

 

52,561

 

Other liabilities

 

 

368,476

 

 

 

358,286

 

Total liabilities

 

$

2,934,890

 

 

$

2,852,835

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies (Note 13)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity

 

 

 

 

 

 

 

 

H.B. Fuller stockholders’ equity:

 

 

 

 

 

 

 

 

Preferred stock (no shares outstanding) shares authorized – 10,045,900

 

 

 

 

 

 

Common stock, par value $1.00 per share, shares authorized – 160,000,000, shares outstanding – 53,859,908 and 53,676,576 as of June 3, 2023 and December 3, 2022, respectively

 

$

53,860

 

 

$

53,677

 

Additional paid-in capital

 

 

280,120

 

 

 

266,491

 

Retained earnings

 

 

1,782,215

 

 

 

1,741,359

 

Accumulated other comprehensive loss

 

 

(433,705

)

 

 

(451,357

)

Total H.B. Fuller stockholders’ equity

 

 

1,682,490

 

 

 

1,610,170

 

Non-controlling interest

 

 

667

 

 

 

624

 

Total equity

 

 

1,683,157

 

 

 

1,610,794

 

Total liabilities, non-controlling interest and total equity

 

$

4,618,047

 

 

$

4,463,629

 

CONSOLIDATED STATEMENTS of CASH FLOWS

H.B. Fuller Company and Subsidiaries

(In thousands)

 

 

Six Months Ended

 

 

 

June 3, 2023

 

 

May 28, 2022

 

Cash flows from operating activities:

 

 

 

 

 

 

 

 

Net income including non-controlling interest

 

$

62,338

 

 

$

85,546

 

Adjustments to reconcile net income including non-controlling interest to net cash (used in) provided by operating activities:

 

 

 

 

 

 

 

 

Depreciation

 

 

39,163

 

 

 

36,333

 

Amortization

 

 

37,813

 

 

 

36,412

 

Deferred income taxes

 

 

(16,831

)

 

 

(4,961

)

Income from equity method investments, net of dividends received

 

 

(2,338

)

 

 

(2,649

)

Debt issuance costs write-off

 

 

2,689

 

 

 

 

Loss on mark to market adjustment on contingent consideration liability

 

 

(220

)

 

 

 

Loss on sale or disposal of assets

 

 

(42

)

 

 

(1,087

)

Share-based compensation

 

 

10,953

 

 

 

13,625

 

Pension and other post-retirement benefit plan activity

 

 

(6,226

)

 

 

(9,720

)

Change in assets and liabilities, net of effects of acquisitions:

 

 

 

 

 

 

 

 

Trade receivables, net

 

 

66,896

 

 

 

(35,491

)

Inventories

 

 

8,285

 

 

 

(95,413

)

Other assets

 

 

(36,951

)

 

 

(21,908

)

Trade payables

 

 

(20,301

)

 

 

27,237

 

Accrued compensation

 

 

(42,190

)

 

 

(40,448

)

Other accrued expenses

 

 

(9,988

)

 

 

4,402

 

Income taxes payable

 

 

10,025

 

 

 

(5,864

)

Other liabilities

 

 

7,866

 

 

 

(23,597

)

Other

 

 

(2,544

)

 

 

28,452

 

Net cash provided by (used in) operating activities

 

 

108,397

 

 

 

(9,131

)

 

 

 

 

 

 

 

 

 

Cash flows from investing activities:

 

 

 

 

 

 

 

 

Purchased property, plant and equipment

 

 

(82,578

)

 

 

(69,055

)

Purchased businesses, net of cash acquired

 

 

(103,744

)

 

 

(229,314

)

Proceeds from sale of property, plant and equipment

 

 

2,623

 

 

 

1,269

 

Cash received from government grant

 

 

 

 

 

3,928

 

Net cash used in investing activities

 

 

(183,699

)

 

 

(293,172

)

 

 

 

 

 

 

 

 

 

Cash flows from financing activities:

 

 

 

 

 

 

 

 

Proceeds from issuance of long-term debt

 

 

1,300,000

 

 

 

335,000

 

Repayment of long-term debt

 

 

(1,176,650

)

 

 

 

Payment of debt issuance costs

 

 

(10,214

)

 

 

(600

)

Net payment of notes payable

 

 

(239

)

 

 

3,565

 

Dividends paid

 

 

(21,258

)

 

 

(18,965

)

Contingent consideration payment

 

 

 

 

 

(5,000

)

Proceeds from stock options exercised

 

 

4,193

 

 

 

7,837

 

Repurchases of common stock

 

 

(2,552

)

 

 

(3,609

)

Net cash provided by financing activities

 

 

93,280

 

 

 

318,228

 

 

 

 

 

 

 

 

 

 

Effect of exchange rate changes on cash and cash equivalents

 

 

5,295

 

 

 

(9,562

)

Net change in cash and cash equivalents

 

 

23,273

 

 

 

6,363

 

Cash and cash equivalents at beginning of period

 

 

79,910

 

 

 

61,786

 

Cash and cash equivalents at end of period

 

$

103,183

 

 

$

68,149

 

 

Steven Brazones

Investor Relations Contact

651-236-5060

KEYWORDS: United States North America Minnesota

INDUSTRY KEYWORDS: Chemicals/Plastics Manufacturing

MEDIA:

Logo
Logo